Reliv International, Inc  

(Public, NASDAQ:RELV)   Watch this stock  
Find more results for Brett P. Ryan �
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.06 - 2.17
Open     -
Vol / Avg. 0.00/11,167.00
Mkt cap 14.36M
P/E 20.87
Div/yield 0.01/1.79
EPS 0.05
Shares 12.82M
Beta 1.86
Inst. own 7%
Apr 30, 2015
Q1 2015 Reliv International Inc Earnings Release
Mar 4, 2015
Q4 2014 Reliv International Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 7.09% 1.26%
Operating margin 3.64% 0.17%
EBITD margin - 1.84%
Return on average assets 14.99% 2.66%
Return on average equity 24.36% 4.37%
Employees 208 -
CDP Score - -


136 Chesterfield Industrial Blvd P O Box 405
United States - Map
+1-636-5379715 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Reliv’ International, Inc. is a developer, manufacturer and marketer of a line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. The Company sells its products through an international network marketing system using independent distributors. It has sold products in the United States since 1988 and in selected international markets since 1991. It offers 18 nutritional supplements, a line of 5 skin care products and an all-natural sweetener. The Company’s core line of nutritional supplements, which represented 52.5% of net product sales for the year ended December 31, 2013, includes: Reliv Classic and Reliv NOW, two basic nutritional supplements containing a full and balanced blend of vitamins, minerals, proteins and herbs; Innergize! an isotonic sports supplement in two flavors and FibRestore, a high-fiber and antioxidant supplement.

Officers and directors

Robert L. Montgomery Jr. Chairman of the Board, Chief Executive Officer
Age: 72
Bio & Compensation  - Reuters
Ryan A. Montgomery President
Age: 41
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Carl W. Hastings Ph.D. Vice Chairman of the Board, Chief Scientific Officer
Age: 73
Bio & Compensation  - Reuters
Steven D. Albright Chief Financial Officer, Senior Vice President
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brett M. Hastings Chief Operating Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Steven G. Hastings Executive Vice President - Sales and Marketing
Age: 49
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
R. Scott Montgomery Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen M. Merrick Senior Vice President, General Counsel, Secretary
Age: 73
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Debra P. Hellweg Vice President - Operations
Age: 43
Bio & Compensation  - Reuters
Kurt C. Wulff Vice President - Marketing
Age: 50
Bio & Compensation  - Reuters